Cite
HARVARD Citation
Clouthier, D. et al. (2019). An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE). Journal for immunotherapy of cancer. 7 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Clouthier, D. et al. (2019). An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE). Journal for immunotherapy of cancer. 7 (1), p. . [Online].